This article is more than 5 years old. Information may no longer be current.

FDA grants approval for generic glaucoma drug

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BUFFALO GROVE, Ill. — The Food and Drug Administration granted marketing approval to Akorn for its solution of brimonidine tartrate for the treatment of glaucoma. The active ingredient is also found in Allergan’s Alphagan line.

Akorn noted this is its first product approval since a manufacturing facility inspection in 2005 was successful.